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LA GESTIONE DELLA FUNZIONE INTESTINALE NEL PAZIENTE 
CON LESIONI DEL SISTEMA NERVOSO CENTRALE
MONTECATONE “BOWEL MANAGEMENT” REGIMEN 
balancing the diet, with a return to normal
relationships between fats, protein and 
carbohydrats
correcting any deficiencies or malnutrition
administration of probiotics and dietary fibre
weaning from oral laxatives
scheduling of evacuation with evacuants
patient on the toilet
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ENTEROTYPES OF THE HUMAN GUT MICROBIOMA
Between-class analysis, which visualizes results from PCA and 
clustering, of the genus compositions of 33 Sanger 
metagenomes estimated by mapping the metagenome reads to 
1, 511 reference genome sequences using an 85% similarity 
threshold
 By combining 22 newly sequenced 
faecal metagenomes of individuals 
from four countries  three robust 
clusters were identified that are not 
nation or continent specific
 Intestinal microbiota variation is 
generally stratified, not continuous. 
This indicates further the existence of 
a limited number of well-balanced 
host–microbial symbiotic states that 
might respond differently to diet and 
drug intake.
The enterotypes are mostly driven 
by species composition:  
Bacteroides; Prevotella, 
Ruminococcus
Arumugam M et al. Nature 2011; 473; 174-180
LINKING LONG-TERM DIETARY PATTERNS WITH GUT MICROBIAL 
ENTEROTYPES
 The enterotypes were strongly associated with diet, 
particularly protein and animal fat (Bacteroides genus) versus 
carbohydrates (Prevotella genus).  Both Bacteroides and 
Prevotella are broad genera of bacteria species that typically live 
in the human gut. Humans tend to have mostly a species from one 
bacterial group but not both. Vegetarians were more likely to be 
in the Prevotella group, the enterotype associated with diets 
enriched in carbohydrates and lacking meat, and the one vegan 
was also in the Prevotella group.
Subsequently, 10 healthy volunteers were enrolled in a 
controlled feeding experiment in which their diets were fixed for 
a 10-day period. All ten subjects in the controlled-feeding 
experiment were in the Bacteroides group at the start, during, 
and at the end of the experiment. Their gut microbiomes changed 
within one day but stayed within the same broad Bacteroides 
group, even if they ate a diet high in carbohydrates over the 10-
day period, emphasizing the short-term stability of the 
enterotypes
Wu GD et al. Science 2011; Sep 1 (Epub ahead of print)
Gut dweller: Prevotella melaninogenica is 
one of the many bacterial species living in 
the human intestine whose roles are now 
exploring
REGIONAL DIFFERENCES IN FERMENTATIVE ACTIVITIES 
OF BACTERIA GROWING IN THE LARGE INTESTINE
Descending colon
Little carbohydrate 
fermentation
Concentration of 
products of protein 
fermentation
(phenols, indoles, 
ammonia) increase
Total SCFA ca 90 
mmol/L
pH 6.6 – 6.9
Sigmoid rectum
Caecum
Ascending colon
Active fermentation
High bacterial 
growth rates
Total SCFA ca 127 
mmol/L
pH 5.4 – 5.9
Transverse colon
Reduction in bacterial activity due to
depletion of substrates
Total SCFA ca 117 mmol/L
pH 6.2
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Am College Gastroenterol Functional Gastrointestinal Disorders Task Force.  Am J Gastroenterol 2005; 100: S1-S21.
PSYLLIUM improves stool frequency and consistency 
compared with placebo
POLYETHYLENE GLYCOLE appears superior to placebo 
for improving stool frequency and stool consistency
LACTULOSE is also more effective than placebo in 
improving stool frequency and stool consistency
5-HT4 receptor agonist TEGASEROD is superior to 
placebo in improving stool frequency, stool consistency, and 
global chronic constipation symptoms
EVIDENCE BASED MEDICINE:
THERAPY OF CONSTIPATION
SUBSTRATES FOR COLONIC BACTERIAL GROWTH
DIETARY FIBER
UNDIGESTED STARCHMUCUS & GLYCOPROTEINS
Daily Fecal Bacterial Output
Stephen AM et al. Gastroenyerology 1983
COMPOSIZIONE E FONTE ALIMENTARE DELLE FIBRE 
NON SOLUBILI
FIBRA COMPOSIZIONE FONTE ALIMENTARE
CELLULOSA
Polisaccaridi di riserva 
(polimeri non ramificati 
del glucosio)
Crusca di grano, cereali 
integrali, legumi, frutta
EMI
CELLULOSA
Polisaccaridi
Polimeri a catena ramificata
Pentosi (arabinosilani, xilani) ed 
Esosi (galattani)
Crusca non di grano, cereali 
integrali, verdure, granaglie
LIGNINA
Materiale non 
polisaccaridico (polimeri 
del fenilpropano ecc.)
Frumento, verdura, frutta 
(fragole, pere, pesche, 
prugne)
COMPOSIZIONE E FONTE ALIMENTARE DELLE FIBRE SOLUBILI
FIBRA COMPOSIZIONE FONTE ALIMENTARE
PECTINA Polisaccaridi, polimeri dell’Ac. 
Gallatturonico e glucuronico 
(ramnosio, galattosio, xilosio, 
fucosio, arabinosio)
Patate dolci, carote, fagioli, 
mele, agrumi
EMIL
CELLULOSA A
Galattomannani e glucomannani Legumi, verdure, frutta
GOMME
Plisaccaridi di riserva
Crusca, avena, derivati 
dell’acacia, verdure, fagioli e 
altri legumi
MUCILLAGINI
Mucopolisaccaridi
(psillium, guar, ispaghula)
Crusca non di grano, cereali 
integrali, verdure, granaglie
ALGHE
Polisaccaridi solforati
(agar, carragenina) e non 
solforati(alginati)
Alghe
Le fibre non debbono essere considerate solo semplice 
materiale non assorbibile, ma nutrienti a tutti gli effetti, con un 
ruolo senz’altro in gran parte ancora da definire,
indubbiamente differente da quello restrittivo finora accettato
(“effetto massa” nella stipsi, “agente saziante”nell’obeso……).
Koruda MJ. Dietary fiber and gastrointestinal disease. Sur Gyn Obst 1993; 177: 209-14
STIPSI FUNZIONALE
SINDROME DELL’INTESTINO IRRITABILE
DIARREA FUNZIONALE
SINDROME DA DEFECAZIONE OSTRUITA
IPERCOLESTEROLEMIA
DIABETE
PREVENZIONE DEL CANCRO DEL COLON
Patologie in cui è indicata la supplementazione della dieta
con fibre alimentari
GUT BACTERIA IN CONSTIPATION
FOS, GOS and INULIN are effective as well as
alimentary fiber in constipation
Their action is a bifidogenic effect with a significant
increase in bifidobacterial numbers, concomitant with a
decrease in the number of bacteriodes, fusobacteria and
clostridia
Sequence comparison reveales that the major shifts
were within previously unknown bacterial taxa
Tannock GW et al. Appl Environ Microbiol 2004; 70: 2129-36. 
Tuohy KM et al. Br J Nutr 2001; 86: 341-8.
Apajalahti JHA et al. Appl Environ Microbiol 2002; 68: 4986-995.
“nondigestible food ingredients that beneficially affect the 
host by selectively stimulating the growth and/or activity of 
one or a limited number of bacterial species already 
established in the colon”
GIBSON et al. 1995
Prebiotics: definition
The beneficial effect on the host may result from either suppression of 
the growth of harmful microorganisms or the stimulation of favourable 
organisms (mainly lactobacilli and bifidobacteria)
intake of FOS (15g/d) increased fecal bifidobacteria numbers 10-fold while 
reducing Clostridia and Enterobacteria counts
HAYAKAWA k et al. Microb Ecology Health Dis1990
•in controlled dietary studies intake of FOS (15g/d) 
increased fecal bifidobacteria numbers 10-fold while 
reducing Clostridia and Enterobacteria counts
•The beneficial effect on the host may result from 
either suppression of the growth of harmful 
microorganisms or the stimulation of favourable 
organisms (mainly lactobacilli and bifidobacteria)
HAYAKAWA k et al. Microb Ecology Health Dis1990
Prebiotics
“a live microbial feed supplement which 
beneficially affects the host by improving its 
intestinal microbial balance”
FULLER 1989
Probiotics: definition
“preparation or product containing viable, 
defined microorganisms in sufficient numbers, 
which alters the microflora in a compartment 
of the host and by that exerts health effects in 
this host”
SCHREZENMEIR et al. 2001
Definizione di Probiotico: microrganismi vivi e vitali che 
conferiscono benefici alla salute dell’ospite quando 
consumati, in adeguate quantità, come parte di un 
alimento (compresa l’acqua) o di un integratore.
Alimento/integratore con Probiotico: alimenti/ integratori 
che contengano, in numero sufficientemente elevato, 
microrganismi probiotici in grado di raggiungere 
l’intestino, moltiplicarsi ed esercitare un’azione benefica 
per lo stato di salute/benessere dell’uomo, che quindi deve 
essere specificamente dimostrata utilizzando il prodotto 
pronto per il consumo
Ministero del Lavoro, della Salute e delle Politiche Sociali
WELL-ESTABLISHED and PROPOSED PROBIOTIC HEALTH EFFECTS
 Prevention and/or reduction of duration and complaints of rotavirus-induced or antibiotic-associated
diarrhea
 Alleviation of complaints due to lactose-intolerance
 Modulation of the autochthonous intestinal microflora
 Immunomodulation and/or - regulation
 Reduction of the concentration of cancer-promoting enzymes and/or putrefactive (bacterial) metabolites
in the gut
 Prevention or alleviation of allergies and atopic diseases in infants
 Beneficial effects on microbial aberrancies, inflammation and other complaints in connection with: 
inflammatory diseases of the g.i. tract, Helicobacter pylori infection,  bacterial overgrowth
 Treatment of urogenital infections
 Prevention and alleviation of unspecific and irregular complants of the g.i. tracts in healthy people
 Prevention of respiratory tract infections (common cold, influenza) and other infectious diseases
 Cancer prevention
 Normalization of passing stool and stool consistency in subjects suffering from obstipation or an irritable
colon
 Prevention or therapy of ischemic heart diseases
 Amelioration of autoimmune diseases (e.g. arthritis)
 Hypocholesterolemic effect
 Improvement of mineral absorption
 Improvement of the mouth flora, caries prevention
de Vrese M et al. Adv Biochem Eng Biotechnol 2008
PROBIOTICI
YOVIS,  YOVIS 250 buste Microorganismi lattici e bifidi
VSL#3 buste Microorganismi lattici e bifidi
ENTERUM 2miliardi /5ml Sospensione Spore di Bacillus subtilis
ENTEROLACTIS bustine Lattobacillo casei DG
DICOFLOR 60 bustine Lactobacillus GG
FIORILAC PS buste Lattobacillo Paracasei e Salivarius
ENTEROGERMINA fialoidi Spore di Bacillus subtilis
ENTEROBACILLI 
Proge Farm
bustine Lattobacillo Paracasei e Salivarius
LACTO5 capsule Lattobacilli
BIOFLORIN caps Enterobacterio
FERLACTIS fialoidi Lattobacilli
FERMENTURTO-LIO flaconi Lattobacilli
LACTEOL FORTE Bustine, cpr Lactobacillus Acidophilus
CODEX buste, cpr Saccharomyces boulardii
INFLORAN BERNA cps Bifidi e lattici
PROBIOX bustine Lattobacilli e Sporogenes
VSL#3 vs. competitors
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Biological effects of Probiotics
2. Immunomodulation
3. Anti-microbial
Activity
4. Enhanced Barrier Integrity
•prevents mucus degradation
•stimulates MUC gene expression
•Directly affect epithelial resistance
1. Competitive Exclusion
Of Bacterial Adhesion/translocation
sIgA
increase IL-10
decrease TNF/IFN
•decrease pH [scfa]
•bacteriocins
•H2O2
5. Binding on endogenous irritants
like bile acids
“I think we are just at the very
beginning of understanding the 
contribution it may make”
Thomas Brandt
Albert Einstein College of Medicine
New York
American College of Gastroenterology
Washington Oct. 28-Nov. 2 
In:
C Diff. Colitis (Khoruts A. University of Minnesota)
IBB
IBS
Obesity – Metabolic Syndrome
Type 1 diabetes
Multiple Sclerosis
Myoclonus Dystonia (Borody JA. Sidney)
Fecal transplants 
“product in which a probiotic and a 
prebiotic are combined”
Synbiotic: definition
: razionale
To improve survival of the probiotic bacteria during the 
passage through the upper intestinal tract and a more 
efficient implantation in the colon togheter with a  
stimulating effect of the prebiotic on the growth of both 
the exogeneous(probiotic) and endogenous bacteria
CONSTIPATION  ILLNESS
BENEFIBRA Fibra di Gomma Guar PHGG
DICOPLUS 100 Glucomannano
DULCOFIBRE Glucomannano
ECAMANNAN Glucomannano
ENTEROLACTIS DUO Inulina + Lactobacillus casei 
F.D. FIBRE Fibre sol. da resina di acacia + F.O.S. + fibra insol. da crusca di grano
FIBROLAX Ispaghula Husk + senna
FLORTEC Frutto-oligosaccaridi + arabin.galattano +Lactobacillus Paracasei B21060
GENEFILUSF19 Gluco-oligosaccaridi + Lactibacillus paracasei subsp. paracaseiF19 
LIPIDYUM Fibra di Psyllium
IDO.NORM Frutto-oligosaccaridi
PLANTEN Fibra di Pyllium
PLANTALAX Fibra di Psyllium
PROBINUL Inulina + Bifidi – Lattici – S. Thermophilus
PSYLLOGEL FIBRA Fibra di Psyllium
PSYLLOGEL MEGA FERMENTI Fibra di Psyllium + Lattici e Bifidi
PSYLLOPLUS Fibra di Psyllium
TUBES COLON Glucommanano + Frutto-oligosaccaridi + Bifidi e Lattici
ZIRFOS Frutto-oligosaccaridi + Bifidobatteri W11
2in Inulina
FIBRE, PREBIOTICI e SIMBIOTICI
 Stimolare la “formazione” di una massa fecale adeguata in 
termini di volume e consistenza
 Stimolare il “mixing” dei contenuti endoluminali attraverso 
una regolazione dell’attività segmentante circadiana
 Promuovere la motilità ad effetto propulsivo
 Ottenere un riempimento rettale idoneo ad elicitarne la 
percezione
 Favorire una completezza della defecazione evitando residui 
post-evacuativi
TERAPIA MEDICA NELLA STIPSI: obbiettivi
Nome Formulazione Principio
CADIFEN Filtro per infusi Finocchio, Anice verde, Liquerizia, Cumino, 
Camomilla, Coriandolo
DICALMIR Filtro per infusi Finocchio, Anice verde, Liquerizia, Cumino, 
Camomilla, Coriandolo
SINODOR Capsule Clorofilla rameica
SIMECRIN Cpr masticabili, 
Emulsione orale
Simeticone
SINAIRE Cpr α- galattosidasi
MYLICON Cpr, gocce. Simeticone
POLISILON gel Dimeticone
SILISAN cpr Simeticone + calcio pantotenato
Antimeteorici
OUTCOME OF INTESTINAL “REHABILITATION” PROGRAM
 having a defecation “di per sé” it is not the main 
outcome of medical treatment for Constipation 
illness
 our aim must be the physiologic balance of 
intestinal ecosystem and, consequentely, having a 
regular fecal daily output
fibers, prebiotics and probiotics are effective in 
this sense on condition that they can be substrate for 
the resident colonic flora
CONCLUSIONI
Stipsi non come mancato “scarico
di residui tossici”, ma come
espressione di un’alterazione
dell’ecosistema intestinale, il cui
riequilibrio è il vero obiettivo
della terapia
BOWEL DYSFUNCTION IN SCI
THE KEY THERAPEUTIC GOALS:
 decreasing time devoted to bowel management
 guarantee of total anal continence between scheduled
evacuations
 avoiding high laxative dosages per os, digital stimulation or
digital defecatory maneuvers
minor dependence on a third person
 defecation on the toilette
Diet and fluid, lifestyle alterations, laxatives, constipating medicine
Digital stimulation, suppositories, biofeedback
Antegrade colonic irrigation
Transanal irrigation
Sacral nerve stimulation
Stoma
STEPWISE APPROACH IN TREATMENT OF DEFECATION DISORDERS in 
PTS with NEUROLOGICAL DISEASES
Krogh K, Christensen P, Laurberg S. Acta Neurol Scand 2001
Christensen P, Bazzocchi G et al. Gastroenterology 2006
MALONE ANTEGRADE 
CONTINENCE ENEMA 
procedure is a simple operation 
which brings out the appendix 
to skin level forming an 
appendicostomy.
Through the stoma patients 
can introduce a catheter and 
administrate an enema.
Due to the wash-out effect and 
perhaps the stimulated colonic 
propulsion, the colon and 
rectum will empty.
Christensen P et al. Spinal Cord 2000; 38: 255-61.
Antegrade colonic irrigation with both an appendicostomy and a colostomy
Worsoe J et al. Dis Colon Rectum 2008; 51: 1523-8
ENEMA CONTINENCE 
CATHETER 
for Trans Anal 
Irrigation : 
successful bowel 
management in Fecal 
Incontinence and 
Constipation of 
patients with SCI
Christensen P et al.
Spinal Cord 2000; 38: 255-61.
PULSED IRRIGATION EVACUATION 
(PIE)
Biotrol ® Irrimatic pump (Braun ®)
Battery driven pump for colonic irrigation.
The cone shaped colostomy tip can also be used to transanal administration of 
enemas
PERISTEEN®  by COLOPLAST
TRANS ANAL IRRIGATION SYSTEM WITH CONSTANT PRESSURE
Anterior view of the 111In-labeled bowel content 
before washout (A) and after (B): the colon is 
empty anal to the left colic flexure
Christensen P et al. Dis Colon Rectum 2003: 46:68-76
SCINTIGRAPHIC ASSESSMENT OF
RETROGRADE COLONIC WASHOUT
A B
Anterior view of the 111In-labeled bowel content 
before washout (A) and after (B): the colonic 
emptying reaches the the left colic flexure
Christensen P et al. Dis Colon Rectum 2003: 46:68-76
SCINTIGRAPHIC ASSESSMENT OF
RETROGRADE COLONIC WASHOUT
A B
Abdominal x-ray 
film in a pts with 
SCI after 6 days 
where 10 
radioopaque 
markers were 
taken daily.
Patient (CF) had 
only 1 bowel 
movement 
during study 
week
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film in the same 
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TRANS ANAL 
IRRIGATION
Abdominal x-ray 
film in a pts with 
SCI after 6 days 
where 10 
radioopaque 
markers were 
taken daily.
Patient (ZCL) 
reported daily 
bowel movement
Abdominal x-ray 
film in the same 
pts (ZLC) after 
TRANS ANAL 
IRRIGATION with 
PERISTEEN
Abdominal x-ray 
film in a pts with 
SCI after 6 days 
where 10 
radioopaque 
markers were 
taken daily.
Patient (DW) had 
only 1 bowel 
movement 
during study 
week
Abdominal x-ray 
film in the same 
pts (DW) after 
one session with  
TRANS ANAL 
IRRIGATION
COLONIC EMPTYING AFTER A NEW TRANS 
ANAL IRRIGATION SYSTEM IN PATIENTS WITH 
SPINAL CORD INJURY
Participants
12 SCI (8 males, 36±13 yrs, range 26-74 yrs) patients
with constipation according to the Rome II Diagnostic
Criteria for The Functional Intestinal Disorders.
- 4 tetraplegic, all with ASIA score A
- 8 paraplegic: 6 with ASIA score A, 2 with ASIA score B
underwent   to the Intestinal Transit Study and TAI procedure
Colonic Emptying After A New Transanal Irrigation 
System In Patients With Spinal Cord Injury
in 12 pts mean Total Transit Time was 5.2±1.1 days (range 3.5-6.5)
in relationship to 2.3±1.1 bowel motions per week (range: 1-4)
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Bazzocchi G. et al. Journal Spinal Cord Injury 2006
CONCLUSIONS
1) this study confirms that constipation in SCI pts is related to 
a very slow colonic transit
2) in SCI, defecation is incomplete since there is a 
discrepancy between markers retained number and bowel 
motion frequency
3) retrograde colonic irrigation by means of Peristeen ® is 
effective for inducing a complete emptying of the left colon 
and rectosigmoid tract
Between December 2003 and June 2005
87 SCI patients with colorectal dysfunction
42 pts in the Trans Anal Irrigation group
29 Males, mean age 47.5 12 years
ASIA score (complete/incomplete) T9 and above 21/10    T10-L2  5/6
45 pts to conservative bowel management
33 Males, mean age 50.6 14 years
ASIA score (complete/incomplete): T9 and above (22/11) T10-L2 (5/7)
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BOWEL FUNCTION SCORES
p =.0002                             p = .034
p =.00016
Bowel function was assessed using three different scores
Constipation: Cleveland Clinic Costipating Score System (range 0-30, 30 = severe symtoms)
Incontinence: St. Mark’s Fecal Incontinence Grading System (range 0-24, 24 = severe symptoms)
NBD-score: Neurogenic Bowel Dysfunction Score (range 0-47, 47 =severe symptoms)
Student’s t-test
Christensen P, Bazzocchi G et al. Gastroenterology 2006
SYMPTOM-RELATED QUALITY OF LIFE
p =.03        p = .00006       p = .037         p = 0053
Symptom-related quality of life was assessed using a modification of the American Society o Colorectal 
Surgeon Fecal Incontinence Score from which four subscales can be extracted
Lifestyle (range 1-4, 4 high QoL)
Coping/behavior (range 1-4, 4 high QoL)
Depression/self perception (1-5, 5 high QoL)
Embarrassment (range 1-4, 4 = high QoL)
0
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embarrassment
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Conservative
Christensen P, Bazzocchi G et al. Gastroenterology 2006
Significantly more independence
Half an hour is saved 
every day
Personal independence is 
regained
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less dependent of help after 10 weeks
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n = 43
Peristeen Irrigation
n = 37
Christensen P, Bazzocchi G et al. Gastroenterology 2006
Other interesting findings
Low incidence 
of UTIs
A safe & well-
tolerated 
method
Only 5.9% of patients had 
UTI 
- vs. 15.5% when using 
conservative bowel 
management method
Fewer incidences of 
symptoms. 
Tendency towards reducing 
symptoms of autonomic 
dysreflexia
Christensen P, Bazzocchi G et al. Gastroenterology 2006

TRANSAL IRRIGATION IN MYELOMENINGOCELE CHILDREN: AN ALTERNATIVE,
SAFE AND VALID APPROACH FOR NEUROGENIC CONSTIPATION
Ausili E, Focarelli B, Tabacco F, Murolo D, Sigismondi M, Gasbarrini A, Rendeli C.
Spinal Cord 2010
Ausili E et al.  2010
LONG-TERM OUTCOME AND SAFETY OF TRANSANAL IRRIGATION FOR 
CONSTIPATION AND FECAL INCONTINENCE
163 patients (47%) had a succesful outcome of treatment: 145 pts
Christensen P et al. Dis Colon Rectum 2009; 52: 286-292.
over 348 were still using TAI
after a mean follow-up of 21
months.
Significant difference was
found between groups
(log-rank test, p<.003)
LONG-TERM OUTCOME AND SAFETY OF TRANSANAL IRRIGATION FOR 
CONSTIPATION AND FECAL INCONTINENCE
Reasons for failure of TAI treatment
Christensen P et al. Dis Colon Rectum 2009; 52: 286-292.
Reason                                                  n = 185, n, (%)
Unsatisfactory effect 76 (41)
Fecal incontinence 30 (16)
Time consumption 23 (12)
Dislike treatment 22 (12)
Side effects 27 (15)
Leakage of  irrigation fluid 16  (9)
Expulsion of  the rectal catheter 8    (4)
Others 10  (5)


COST-EFFECTIVENESS OF TRANSANAL IRRIGATION VERSUS CONSERVATIVE 
BOWEL MANAGEMENT FOR SPINAL CORD INJURY PATIENTS
Costs of the two bowel management methods
Christensen P et al. Dis Colon Rectum 2009; 52: 286-292.
Conservative bowel             
management                    TAI  
Labour cost
Cost of carer helping with bowel management
and changes/baths because of soiling € 9 € 6
Product-related cost
Cost related to products used for changes/baths
because of soiling, products for TAI, and
constipation medicine € 4 €16
Urinary tract infection cost
Cost for general practitioner visit, urine test,
antibiotics € 3 € 1
Patient indirect expenditure
Patient productivity loss because of time spent €23 €15
TOTAL COST TO SOCIETY €39 €38
Costs reported for a 2-day period, corresponding to average interval between bowel management procedures
1st step:
- balanced diet
- planning for evacuation with bysacodil
suppositories  and/or enema
2nd step in addition to 1st step:
- Macrogol 
- fibers and/or prebiotics + probiotics 
“Quality” parameters:
- Time for bowel care < 30 min
- No failure
- No manual manouvers for the evacuation
- No cathartic laxatives per os
- Continence guarantee in the interval between a 
planned evacuation and the successive one
- Minimum dependance on other caregivers
- Use of the toilet/commode
- Complete evacuation - lack of retained fecal
after defecations
MONTECATONE “BOWEL MANAGEMENT” REGIMEN
3rd step in addition to previous two:
- regular colonic retrograde irrigation
session with  Peristeen 
Bazzocchi G. Ital J Rehab Med 2006
Salvioli B. et al Urodinamica 2007
Trattamento conservativo, 
gestito dalla Unità Spinale
PROBLEMI SODDISFAZIONE
UO  Riabilit. Gastroenterol:
apporto di fibra solubile,
PEG, prebiotici, probiotici
PROBLEMI, 
INSUCCESSO
Criteri di inclusione ed 
esclusione per la TAI 
con il Peristeen
NO
Clismi, rettoclisi, misure 
evacuanti, lassativi
INEFFICACIA
Chirurgia, 
Neuromodulazione
SI
Presentazione 
del Peristeen 
al paziente CONSENSO
RIFIUTO
Preparazione intestinale
Addestramento eseguito in 
ospedale da personale 
esperto in almeno 3 sedute
Procedura per il 
rimborso: AUSL, 
INAIL ecc.
Utilizzo della TAI con il 
Peristeen per almeno 2 
mesi 
MALFUNZIONAMENTO
Aggiustamenti, 
personalizzazione del protocollo, 
terapie associate
